Brian R. Gastman
Plastic Surgery
9500 Euclid Avenue, A60
Cleveland Clinic
Cleveland, OH 44195
Cleveland Clinic
Cleveland, OH 44195
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 159 publications
Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC).
Journal: Journal for immunotherapy of cancer
Published: February 09, 2026
Real-World, Evidence-Based, Retrospective Study of Patients Infused with Commercially Released Lifileucel for Advanced Melanoma.
Journal: Transplantation and cellular therapy
Published: February 05, 2026
Correction: NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma model.
Journal: Scientific reports
Published: December 18, 2025
Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory Hurdles.
Journal: Transplantation and cellular therapy
Published: December 04, 2025
Lymphotoxin-driven cancer cell eradication by tumoricidal CD8+ TIL.
Journal: bioRxiv : the preprint server for biology
Published: December 03, 2025
Indocyanine Green-Guided Sentinel Lymph Node Biopsy in Melanoma: Assessing Clinical Value in a Cohort Over 1000 Patients.
Journal: Journal of surgical oncology
Published: November 04, 2025
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.
Journal: Journal for immunotherapy of cancer
Published: October 29, 2025
Treatment effect of neoadjuvant immunotherapy in melanoma correlates with tumor burden: meta-analysis of reported clinical trials.
Journal: Melanoma research
Published: October 13, 2025
ASO Author Reflections: Antibiotic Prophylaxis for SSI Prevention in Tissue Expander Breast Reconstruction: How Much is Enough?
Journal: Annals of surgical oncology
Published: October 07, 2025
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: July 04, 2025
Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 02, 2025
Last Updated: 09/26/2026